Retina Benchmark Overview

• Retina Benchmark is a curated, protocol-driven resource defining datasets and evaluation metrics for retinal imaging, enhancement, segmentation, and anomaly detection.
• It standardizes rigorous evaluation through annotated data, expert scoring, and multi-fold splits to ensure reliable comparison of algorithms and device performance.
• The benchmarks support advancements in clinical grading, artificial retina systems, and hardware efficiency by integrating diverse metrics and cross-domain protocols.

A "Retina Benchmark" refers to any curated, protocol-driven dataset or evaluation resource for measuring algorithmic or biological performance related to the retina—either in biomedical imaging, electronic vision systems, or theoretical modeling of retinal function. Such benchmarks encompass diverse domains, from clinical image analysis (e.g., fundus photos, optical coherence tomography angiography) and event-based vision, to artificial-retina-inspired pattern recognition in high-energy physics and neurophysiological quantification of predictive coding. Retinal benchmarks serve as foundational resources for the standardized assessment and comparison of algorithms, device architectures, or biological hypotheses.

1. Large-Scale Retinal Imaging Benchmarks

Retinal imaging benchmarks typically comprise annotated datasets of fundus photographs or optical coherence tomographic images—often targeting automated disease grading, image quality assessment, or segmentation of vascular and neural structures.

• OCTA-25K-IQA-SEG is the largest publicly available benchmark for Optical Coherence Tomography Angiography (OCTA), providing 25,665 images across four subsets: sOCTA-3×3-10k (10,480 3×3 mm² superficial scans), sOCTA-6×6-14k (14,042 6×6 mm² superficial scans), sOCTA-3×3-1.1k-seg (1,101 superficial scans with pixelwise FAZ masks), and dOCTA-6×6-1.1k-seg (1,143 deep scans with FAZ masks), all acquired on Topcon Triton SS-OCTA and rescaled to 320×320 px (Wang et al., 2021). The dataset includes three-way image quality labels and expert-reviewed segmentation, with rigorous inter-observer consistency checks and multi-fold splits for robust evaluation.
• EyeBench introduces a clinically aligned, multidimensional evaluation framework for fundus image enhancement, leveraging 28,791 EyePACS images with EyeQ-derived quality annotations and DR grading (Zhu et al., 20 Feb 2025). EyeBench distinguishes itself by providing protocols for both paired (real-synthetic) and unpaired enhancement evaluations, integrating not only traditional denoising metrics (MSE, PSNR, SSIM), but also downstream tasks (vessel segmentation, lesion segmentation, DR grading), as well as expert-centric lesion/vessel-preservation criteria.
• RETA (REtinal vascular Tree Analysis) sets a benchmark for vascular tree segmentation and analysis, with 81 high-resolution (1024×1024) color fundus images from the IDRiD challenge, annotated through a semi-automated, coarse-to-fine workflow using the MATLAB-based CARL tool (Lyu et al., 2021). RETA contains binary vessel masks, artery/vein/crossover labels, vascular skeletons, bifurcations, full tree graphs, abnormality annotations, and thickness masks. Both subjective expert scoring and objective measures (fractal dimension, topological error metrics) support quality validation.

2. Algorithmic Benchmarking: Disease Grading, Segmentation, Enhancement

Benchmarks not only provide data but define protocols, metrics, and canonical baselines for algorithmic development in retinal analysis.

• Diabetic Retinopathy Grading: The EyePACS-derived benchmark supports 5-class DR grading, with dynamic batch balancing and compact deep CNN architecture (927,911 parameters) yielding quadratic weighted κ of 0.767 and robust performance under class imbalance, though ensemble-based solutions achieve κ>0.84 (Trivino et al., 2018).
• OCTA Quality Assessment and FAZ Segmentation: OCTA-25K-IQA-SEG prescribes five ImageNet-pretrained deep learning backbones for 3-way quality classification (ResNet-101, Inception-V3, EfficientNet-B7, SE-ResNeXt-101, Swin-Transformer-Large), with the Swin-Transformer-Large backbone attaining 0.91 accuracy, 0.91 F1, and AUC≈0.98 on 3×3 mm² scans. FAZ segmentation utilizes an nnU-Net-derived architecture, achieving Dice=0.95/0.89 for superficial/deep scans, reflecting near-expert pixelwise agreement (Wang et al., 2021).
• Fundus Image Enhancement: EyeBench demonstrates that full-reference paired methods (e.g., GFE-Net, SSIM = 0.9554, PSNR = 29.72 dB) outperform leading unpaired generative models (CycleGAN, OTEGAN), yet high PSNR/SSIM alone does not ensure preservation of vessel or lesion structures essential for clinical application. Notably, scores from EyeBench's downstream tasks (vessel AUC, lesion F1, DR grading κ) and expert lesion/vessel preservation (LPR, SPR) correlate more strongly with clinical utility (Spearman r>0.7) than canonical metrics, indicating the necessity for multidimensional evaluation (Zhu et al., 20 Feb 2025).
• Vascular Tree Segmentation: RETA advocates evaluation by Dice, Jaccard, Branch Point Recall, and skeletal/topological similarity, providing not only masks but graph-based structure and abnormality labels to facilitate research on topologically complex vessel networks (Lyu et al., 2021).

3. Anomaly and Outlier Detection Benchmarks

Systematic benchmarks are now established for open-set and few-shot anomaly detection in retinal imaging.

• BenchReAD combines seven public datasets across fundus and OCT modalities, with stratified training/validation/test splits including seen and unseen anomaly classes (e.g., DR, AMD, optic disc anomalies, myopia, and rare pathologies in fundus; CNV, DME, drusen, ERM, retinal occlusions in OCT) (Lian et al., 14 Jul 2025). Four algorithmic regimes are distinguished: truly unsupervised (SoftPatch), one-class supervised (EDC, SimpleNet, PatchCore), semi-supervised (DDAD-ASR), and (fully) supervised (DRA, NFM-DRA). The DRA model employs disentangled representation learning, fusing orthogonal normal/abnormal features with classification and reconstruction objectives, while the NFM-DRA variant introduces a Normal Feature Memory to improve detection of unseen pathologies.
• Quantitative performance is reported as AUC (area under ROC), F1, sensitivity, specificity for both overall and unseen-category anomaly detection. BenchReAD establishes NFM-DRA as state-of-the-art (e.g., RIADD fundus AUC = 99.3%), with improved robustness and reduced variance on challenging outlier conditions.

4. Artificial Retina Algorithms in Hardware and Perception

Inspired by neurobiological retina, artificial-retina architectures have found application in both silicon visual systems and high-throughput pattern recognition.

• Event-Driven Eye Tracking: The neuromorphic "Retina" benchmark provides the Ini-30 dataset—DVS-camera-based recordings (64×64 event frames) of 30 participants with manually labeled pupil positions (Bonazzi et al., 2023). The SNN architecture (63k parameters, 3.03M MACs/inference) employs stacked spiking convolutional layers and achieves 3.24 px mean centroid error (vs. 4.48 for 3ET), with end-to-end power dissipation of 2.89–4.80 mW on Synsense Speck and latencies <8 ms. Superior accuracy-to-complexity and energy efficiency trade-offs position this as a new low-power edge benchmark.
• Artificial Retina Trackers in HEP: In collider and tracking detector applications, the "retina" algorithm performs parallelized pattern recognition across gridded track-parameter space (Deng et al., 2020, Abba et al., 2014). For LHCb (40 MHz, high pile-up), artificial-retina-based FPGA systems achieve 95% efficiency, 8–12% fake rate, ∼25% curvature-resolution degradation compared to offline baselines, and <1 μs latency for pile-up ≈11 (Abba et al., 2014). Iterative retina algorithms with hardware-efficient grid refinement scale to O(100)× reduction in resources over brute-force scanning, supporting massive parallel data flows in high multiplicity environments (Deng et al., 2020).

5. Quantitative Metrics and Evaluation Protocols

Retina benchmarks standardize both task-relevant and cross-domain quantitative metrics.

• Disease classification and grading: Metrics include overall accuracy, per-class sensitivity/specificity, quadratic weighted Cohen’s κ, and AUC for binary (referable DR) and multiclass settings (Trivino et al., 2018, Zhu et al., 20 Feb 2025).
• Image enhancement and segmentation: In EyeBench and OCTA-25K-IQA-SEG, metrics encompass MSE, PSNR, SSIM for denoising; Dice, Jaccard, vessel AUC, F1 for segmentation; FID for representation consistency; and LPR, BPR, SPR for lesion/vessel preservation (Wang et al., 2021, Zhu et al., 20 Feb 2025).
• Anomaly detection: BenchReAD employs AUC (integrated TPR over FPR), F1, and, uniquely, differential performance for "seen" vs. "unseen" (open-set) pathologies. Memory-augmented methods improve open-set robustness (Lian et al., 14 Jul 2025).
• Hardware retina: Throughput, latency, DSP/LUT/BRAM/FF resource usage, track-finding efficiency, and resolution metrics quantify real-time artificial retina system performance in particle physics (Deng et al., 2020, Abba et al., 2014).
• Neurophysiology benchmarks: Predictive coding in the retina is quantified by time-shifted mutual information (MI), predictive power ($P_p$), and anticipation lag (δt_p) in bits/s and ms, facilitating comparison across species, stimulus statistics, or disease states (Chen et al., 2016).

6. Impact, Access, and Community Adoption

Availability, annotation rigor, and protocol design directly affect benchmark impact and adoption.

• Data access: OCTA-25K-IQA-SEG (https://doi.org/10.5281/zenodo.5111975), EyeBench (https://github.com/Retinal-Research/EyeBench), RETA (https://www.reta-benchmark.org), BenchReAD (https://github.com/DopamineLcy/BenchReAD), artificial-retina code and hardware frameworks are released for academic use, maximizing reproducibility and methodological advancement.
• Annotation protocols: These resources employ multi-observer, multi-stage, or expert-arbitrated annotation for quality assurance—crucial for downstream algorithmic reliability and clinical translation.
• Evaluation protocols: Fixed splits, cross-validation (e.g., 5-fold in OCTA-25K-IQA-SEG), and clear performance reporting standards support rigorous, apples-to-apples comparison and long-term methodological benchmarking.

7. Future Directions and Challenges

Significant challenges persist, anchoring future retinal benchmark research agendas.

• Clinical alignment: Single-metric evaluation is insufficient; multidimensional clinical task alignment and expert-in-the-loop scoring are essential to bridge algorithmic performance and medical relevance (Zhu et al., 20 Feb 2025).
• Open-set and rare event detection: Open-set robustness remains an active area, with NFM-DRA exemplifying current progress but also revealing persistent gaps on highly atypical or rare pathologies (Lian et al., 14 Jul 2025).
• Cross-modality extension: Richly-annotated, structure-aware benchmarks (e.g., RETA) provide a starting point for leveraging vessel segmentation and topological analysis across OCT, MR angiography, and domain-adaptive learning.
• Resource and complexity constraints: Hardware-efficient SNNs and artificial retina systems demonstrate that biological inspiration can yield orders-of-magnitude improvements in energy and latency, redefining edge vision benchmarks (Bonazzi et al., 2023, Deng et al., 2020).
• Neuroinformatics translation: Quantitative neurophysiological benchmarks (e.g., predictive MI in retina) provide a basis for integrative studies of natural and artificial vision, supporting direct comparison across species, pathologies, and computational models (Chen et al., 2016).

In sum, retina benchmarks—spanning imaging, enhancement, segmentation, anomaly detection, hardware realization, and neurophysiological quantification—form the backbone for rigorous algorithmic and translational development in vision science and technology. Their design, metrics, and protocols have a profound influence on methodological progress and clinical impact.